The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShield Thera Share News (STX)

Share Price Information for Shield Thera (STX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.40
Bid: 2.30
Ask: 2.50
Change: 0.00 (0.00%)
Spread: 0.20 (8.696%)
Open: 2.35
High: 2.40
Low: 2.20
Prev. Close: 2.40
STX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Zytronic hit by electronic component shortages

Thu, 09th Feb 2023 11:19

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

Genedrive PLC, up 34% at 33.47 pence, 12-month range 8p-42p. The molecular diagnostics company says the UK's National Institute for Health & Care Excellence has preliminarily recommended its antiobiotic-induced hearing loss test for use in the National Health Service. NICE's final guidance will follow a public consultation period, which will close on February 21. "We encourage relevant stakeholders to participate during the public consultation period to support our pioneering work, and look forward to receiving the final NICE report," says CEO David Budd.

----------

Shield Therapeutics PLC, up 12% at 6.9p, 12-month range 5.5p-36p. The commercial stage pharmaceutical company updates on its annual performance, and now expects revenue of GBP8.5 million, multiplied year-on-year from GBP1.5 million. Says the period was a "landmark" year for Accrufer, its novel oral iron therapy. CEO Greg Madison notes its sales collobration with Viatris is "off to a great start".

----------

AIM - LOSERS

----------

Zytronic PLC, down 11% at 134p, 12-month range 110p-192.49p. The touch sensors manufacturer says the performance in the first four months of its financial year has been hit by ongoing global supply chain issues, leading to a shortage of some electronic components. Consequently, it has needed to buy some of these at a higher price on the "grey market", or cannibalise its existing stock. Also notes potential rising costs from proposed increases to national minimum wage and nation living wage in the UK, as well as wage negotiations with its employee representatives. It now expects revenue to be more weighted towards the second half than in the previous year.

----------

Beowulf Mining PLC, down 8.0% at 3p, 12-month range 2.38p-22.2p. The mining company launches a retail offer of up to 104.0 million new shares at 2.06p, which is around a 31% discount to its closing price on Wednesday. It plans to raise around GBP2.1 million in gross proceeds, which it will put towards its workstreams. Also conducts a preferential rights issue of up to 316.7 million Swedish depositary receipts to raise around GBP6.8 million.

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
19 Sep 2018 08:36

Shield Therapeutics irons losses, agrees commercialisation deal

(Sharecast News) - Iron deficiency treatment specialist Shield Therapeutics narrowed losses as revenues grew in the first half of that saw a series of positive developments.

Read more
13 Sep 2018 11:51

Shield Therapeutics Completes Recruitment For Feraccru Trial

LONDON (Alliance News) - Shield Therapeutics PLC said on Thursday it has completed recruitment of patients for the AEGIS-H2H Phase 3b study of oral Feraccru in subjects suffering from inflammatory

Read more
26 Jul 2018 13:05

Shield Therapeutics Appoints Hans-Peter Hasler To Board

LONDON (Alliance News) - Shield Therapeutics PLC, a commercial stage pharmaceutical company, said Thursday that it has appointed Hans-Peter Hasler as non-executive director with immediate is the a

Read more
20 Jun 2018 16:09

UK Shareholder Meetings Calendar - Next 7 Days

Thursday 21 JuneHSS Hire GroupFriday 22 JuneCambian Fifteen Communications Shipping 25

Read more
14 Jun 2018 13:48

Shield Therapeutics Reports Positive Results From Feraccru Study

LONDON (Alliance News) - Pharmaceutical company Shield Therapeutics PLC said Thursday it has had positive top-line results from its paediatric phase I pharmacokinetics study of its ferric iron is

Read more
12 Jan 2017 09:04

Diurnal Hires Outgoing Mereo BioPharma Finance Chief Bungay

Read more
6 Jan 2017 08:12

Shield Therapeutics sees 'encouraging' demand for oral iron product in England, Germany

(ShareCast News) - AIM-listed pharmaceutical Shield Therapeutics saw "encouraging" demand for its oral iron product in the England and Germany. The company said is seeing "very encouraging signals of demand" after only six months since the commercial launch of Feraccru, which treats of iron deficien

Read more
14 Jun 2016 09:17

Shield Therapeutics Reports Widened Pretax Loss In Maiden 2015 Results

Read more
7 Jun 2016 15:06

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
26 Feb 2016 09:17

Shield Therapeutics Starts Trading, Gets European Feraccru Approval (ALLIPO)

Read more
12 Feb 2016 11:50

Shield Therapeutics Raises GBP32.5 Million In Delayed AIM IPO (ALLIPO)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.